Creative Planning - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$235,000
-16.4%
5,1020.0%0.00%
Q2 2021$281,000
+6.4%
5,102
-0.0%
0.00%
-100.0%
Q1 2021$264,000
-2.9%
5,103
-18.8%
0.00%0.0%
Q4 2020$272,000
+6.2%
6,285
+31.3%
0.00%0.0%
Q2 2020$256,000
+10.8%
4,785
-1.0%
0.00%0.0%
Q4 2019$231,000
-3.3%
4,835
+0.8%
0.00%0.0%
Q2 2019$239,000
-6.3%
4,795
+26.7%
0.00%0.0%
Q1 2019$255,000
-13.0%
3,785
-0.5%
0.00%0.0%
Q3 2018$293,000
-25.6%
3,804
-18.7%
0.00%
-50.0%
Q2 2018$394,000
-64.5%
4,681
-71.9%
0.00%
-60.0%
Q3 2017$1,111,000
+29.2%
16,650
-0.4%
0.01%
+25.0%
Q2 2017$860,000
-10.7%
16,710
+1.4%
0.00%
-20.0%
Q1 2017$963,000
+54.3%
16,482
+10.2%
0.01%
+25.0%
Q4 2016$624,000
+46.1%
14,954
+85.1%
0.00%
+33.3%
Q3 2016$427,000
+24.1%
8,079
-2.4%
0.00%
+50.0%
Q2 2016$344,000
-6.8%
8,279
-8.8%
0.00%
-33.3%
Q1 2016$369,000
-37.5%
9,079
-0.1%
0.00%
-40.0%
Q4 2015$590,000
+104.9%
9,085
+122.4%
0.01%
+66.7%
Q3 2015$288,000
+46.9%
4,085
+96.5%
0.00%
+50.0%
Q1 2015$196,000
+62.0%
2,079
+92.7%
0.00%
+100.0%
Q4 2014$121,000
+89.1%
1,079
+2.8%
0.00%0.0%
Q3 2014$64,0001,0500.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders